View in EDS HTML Full Text PDF Full Text

Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.

Saved in:
Bibliographic Details
Title: Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
Authors: Gillissen, Bernhard1, Wendt, Jana1, Richter, Antje1, Richter, Anja1, Müer, Annika1, Overkamp, Tim1, Gebhardt, Nina1, Preissner, Robert1, Belka, Claus2, Dörken, Bernd1, Daniel, Peter T.3 pdaniel@mdc-berlin.de
Source: Journal of Cell Biology. 3/22/2010, Vol. 188 Issue 6, p851-862. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00219525
DOI:10.1083/jcb.200912070